PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.43%
Revenue growth at 50-75% of MU's 17.08%. Martin Whitman would worry about competitiveness or product relevance.
9.99%
Gross profit growth under 50% of MU's 68.55%. Michael Burry would be concerned about a severe competitive disadvantage.
29.39%
EBIT growth below 50% of MU's 190.81%. Michael Burry would suspect deeper competitive or cost structure issues.
29.39%
Operating income growth under 50% of MU's 190.81%. Michael Burry would be concerned about deeper cost or sales issues.
29.08%
Net income growth under 50% of MU's 396.67%. Michael Burry would suspect the firm is falling well behind a key competitor.
33.33%
EPS growth under 50% of MU's 376.47%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
20.48%
Diluted EPS growth under 50% of MU's 381.25%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.56%
Share reduction while MU is at 5.67%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
5.70%
Diluted share count expanding well above MU's 6.32%. Michael Burry would fear significant dilution to existing owners' stakes.
0.56%
Dividend growth of 0.56% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-40.45%
Negative OCF growth while MU is at 23.46%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-40.16%
Negative FCF growth while MU is at 254.67%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
104.35%
10Y revenue/share CAGR at 75-90% of MU's 127.82%. Bill Ackman would press for new markets or product lines to narrow the gap.
58.19%
5Y revenue/share CAGR at 50-75% of MU's 101.09%. Martin Whitman would worry about a lagging mid-term growth trajectory.
60.18%
3Y revenue/share CAGR above 1.5x MU's 9.16%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
964.73%
10Y OCF/share CAGR above 1.5x MU's 242.42%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
152.62%
5Y OCF/share CAGR 1.25-1.5x MU's 118.89%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
109.07%
Positive 3Y OCF/share CAGR while MU is negative. John Neff might see a big short-term edge in operational efficiency.
186.92%
Below 50% of MU's 1302.52%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
87.97%
Below 50% of MU's 456.91%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
187.54%
3Y net income/share CAGR above 1.5x MU's 17.96%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
166.39%
10Y equity/share CAGR above 1.5x MU's 21.14%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
36.74%
5Y equity/share CAGR at 50-75% of MU's 58.83%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
17.70%
Below 50% of MU's 48.43%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.80%
3Y dividend/share CAGR of 56.80% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
23.14%
AR growth well above MU's 17.86%. Michael Burry fears inflated revenue or higher default risk in the near future.
32.23%
Inventory growth well above MU's 9.09%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.97%
Asset growth well under 50% of MU's 16.23%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
7.37%
BV/share growth of 7.37% while MU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-0.07%
We’re deleveraging while MU stands at 28.70%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.16%
R&D growth drastically higher vs. MU's 0.64%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-1.26%
We cut SG&A while MU invests at 17.61%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.